nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfadiazine—CYP2E1—lung cancer	0.406	1	CbGaD
Sulfadiazine—CYP2C9—Gefitinib—lung cancer	0.0357	0.0954	CbGbCtD
Sulfadiazine—CYP2C9—Teniposide—lung cancer	0.0346	0.0925	CbGbCtD
Sulfadiazine—CYP2C8—Erlotinib—lung cancer	0.0303	0.0809	CbGbCtD
Sulfadiazine—CYP2E1—Etoposide—lung cancer	0.0293	0.0783	CbGbCtD
Sulfadiazine—CYP2C8—Paclitaxel—lung cancer	0.0277	0.074	CbGbCtD
Sulfadiazine—CYP3A4—Topotecan—lung cancer	0.0227	0.0607	CbGbCtD
Sulfadiazine—CYP2C8—Etoposide—lung cancer	0.0219	0.0585	CbGbCtD
Sulfadiazine—CYP3A4—Gefitinib—lung cancer	0.0208	0.0555	CbGbCtD
Sulfadiazine—CYP3A4—Teniposide—lung cancer	0.0201	0.0538	CbGbCtD
Sulfadiazine—CYP2C9—Paclitaxel—lung cancer	0.0193	0.0516	CbGbCtD
Sulfadiazine—CYP3A4—Vinorelbine—lung cancer	0.016	0.0427	CbGbCtD
Sulfadiazine—CYP2C9—Cisplatin—lung cancer	0.0156	0.0415	CbGbCtD
Sulfadiazine—CYP3A4—Crizotinib—lung cancer	0.0127	0.034	CbGbCtD
Sulfadiazine—CYP3A4—Erlotinib—lung cancer	0.0123	0.0328	CbGbCtD
Sulfadiazine—CYP3A4—Paclitaxel—lung cancer	0.0112	0.03	CbGbCtD
Sulfadiazine—CYP3A4—Irinotecan—lung cancer	0.0111	0.0296	CbGbCtD
Sulfadiazine—CYP3A4—Vinblastine—lung cancer	0.00986	0.0263	CbGbCtD
Sulfadiazine—CYP3A4—Etoposide—lung cancer	0.00889	0.0237	CbGbCtD
Sulfadiazine—CYP3A4—Docetaxel—lung cancer	0.00813	0.0217	CbGbCtD
Sulfadiazine—CYP3A4—Doxorubicin—lung cancer	0.00606	0.0162	CbGbCtD
Sulfadiazine—Sulfaphenazole—CYP2A6—lung cancer	0.000428	0.164	CrCbGaD
Sulfadiazine—Sulfasalazine—ABCG2—lung cancer	0.000391	0.15	CrCbGaD
Sulfadiazine—Sulfamethazine—ALB—lung cancer	0.000332	0.127	CrCbGaD
Sulfadiazine—Sulfamerazine—ALB—lung cancer	0.000325	0.124	CrCbGaD
Sulfadiazine—Sulfamethizole—ALB—lung cancer	0.000252	0.0964	CrCbGaD
Sulfadiazine—Sulfanilamide—CYP2E1—lung cancer	0.000226	0.0864	CrCbGaD
Sulfadiazine—Gastrointestinal pain—Topotecan—lung cancer	0.000224	0.0014	CcSEcCtD
Sulfadiazine—Anorexia—Vinorelbine—lung cancer	0.000223	0.0014	CcSEcCtD
Sulfadiazine—Polyuria—Methotrexate—lung cancer	0.000223	0.0014	CcSEcCtD
Sulfadiazine—Skin exfoliation—Doxorubicin—lung cancer	0.000223	0.0014	CcSEcCtD
Sulfadiazine—Abdominal pain—Vinblastine—lung cancer	0.000222	0.00139	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Erlotinib—lung cancer	0.000221	0.00139	CcSEcCtD
Sulfadiazine—Nausea—Teniposide—lung cancer	0.000219	0.00137	CcSEcCtD
Sulfadiazine—Aplastic anaemia—Doxorubicin—lung cancer	0.000219	0.00137	CcSEcCtD
Sulfadiazine—Urticaria—Topotecan—lung cancer	0.000217	0.00136	CcSEcCtD
Sulfadiazine—Body temperature increased—Topotecan—lung cancer	0.000216	0.00135	CcSEcCtD
Sulfadiazine—Abdominal pain—Topotecan—lung cancer	0.000216	0.00135	CcSEcCtD
Sulfadiazine—Body temperature increased—Erlotinib—lung cancer	0.000214	0.00134	CcSEcCtD
Sulfadiazine—Abdominal pain—Erlotinib—lung cancer	0.000214	0.00134	CcSEcCtD
Sulfadiazine—Erythema multiforme—Etoposide—lung cancer	0.000213	0.00134	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Vinorelbine—lung cancer	0.000213	0.00133	CcSEcCtD
Sulfadiazine—Vertigo—Irinotecan—lung cancer	0.000212	0.00133	CcSEcCtD
Sulfadiazine—Leukopenia—Irinotecan—lung cancer	0.000212	0.00133	CcSEcCtD
Sulfadiazine—Erythema multiforme—Paclitaxel—lung cancer	0.000209	0.00131	CcSEcCtD
Sulfadiazine—Hypersensitivity—Vinblastine—lung cancer	0.000207	0.0013	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Docetaxel—lung cancer	0.000207	0.0013	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Methotrexate—lung cancer	0.000207	0.0013	CcSEcCtD
Sulfadiazine—Tinnitus—Paclitaxel—lung cancer	0.000206	0.00129	CcSEcCtD
Sulfadiazine—Leukopenia—Gemcitabine—lung cancer	0.000206	0.00129	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Docetaxel—lung cancer	0.000205	0.00128	CcSEcCtD
Sulfadiazine—Stomatitis—Docetaxel—lung cancer	0.000204	0.00128	CcSEcCtD
Sulfadiazine—Decreased appetite—Vinorelbine—lung cancer	0.000203	0.00127	CcSEcCtD
Sulfadiazine—Chills—Etoposide—lung cancer	0.000203	0.00127	CcSEcCtD
Sulfadiazine—Sepsis—Doxorubicin—lung cancer	0.000202	0.00127	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Methotrexate—lung cancer	0.000202	0.00127	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Vinorelbine—lung cancer	0.000202	0.00127	CcSEcCtD
Sulfadiazine—Hypersensitivity—Topotecan—lung cancer	0.000201	0.00126	CcSEcCtD
Sulfadiazine—Dapsone—CYP2E1—lung cancer	0.000201	0.0771	CrCbGaD
Sulfadiazine—Chills—Paclitaxel—lung cancer	0.000199	0.00124	CcSEcCtD
Sulfadiazine—Arthralgia—Gemcitabine—lung cancer	0.000196	0.00123	CcSEcCtD
Sulfadiazine—Agranulocytosis—Docetaxel—lung cancer	0.000195	0.00122	CcSEcCtD
Sulfadiazine—Pruritus—Topotecan—lung cancer	0.000193	0.00121	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Irinotecan—lung cancer	0.000193	0.00121	CcSEcCtD
Sulfadiazine—Diarrhoea—Vinblastine—lung cancer	0.000193	0.00121	CcSEcCtD
Sulfadiazine—Leukopenia—Cisplatin—lung cancer	0.000192	0.0012	CcSEcCtD
Sulfadiazine—Sulfasalazine—PTGS2—lung cancer	0.000191	0.0733	CrCbGaD
Sulfadiazine—Pruritus—Erlotinib—lung cancer	0.000191	0.0012	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Vinorelbine—lung cancer	0.000191	0.0012	CcSEcCtD
Sulfadiazine—Vascular purpura—Doxorubicin—lung cancer	0.000189	0.00119	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Irinotecan—lung cancer	0.000189	0.00118	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Gemcitabine—lung cancer	0.000188	0.00118	CcSEcCtD
Sulfadiazine—Hepatitis—Docetaxel—lung cancer	0.000188	0.00118	CcSEcCtD
Sulfadiazine—Diarrhoea—Topotecan—lung cancer	0.000187	0.00117	CcSEcCtD
Sulfadiazine—Convulsion—Cisplatin—lung cancer	0.000186	0.00116	CcSEcCtD
Sulfadiazine—Urticaria—Vinorelbine—lung cancer	0.000186	0.00116	CcSEcCtD
Sulfadiazine—Diarrhoea—Erlotinib—lung cancer	0.000185	0.00116	CcSEcCtD
Sulfadiazine—Abdominal pain—Vinorelbine—lung cancer	0.000185	0.00116	CcSEcCtD
Sulfadiazine—Body temperature increased—Vinorelbine—lung cancer	0.000185	0.00116	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Gemcitabine—lung cancer	0.000184	0.00115	CcSEcCtD
Sulfadiazine—Anorexia—Irinotecan—lung cancer	0.000184	0.00115	CcSEcCtD
Sulfadiazine—Ataxia—Methotrexate—lung cancer	0.000184	0.00115	CcSEcCtD
Sulfadiazine—Dermatitis exfoliative—Doxorubicin—lung cancer	0.000179	0.00112	CcSEcCtD
Sulfadiazine—Anorexia—Gemcitabine—lung cancer	0.000179	0.00112	CcSEcCtD
Sulfadiazine—Vomiting—Vinblastine—lung cancer	0.000179	0.00112	CcSEcCtD
Sulfadiazine—Erythema multiforme—Docetaxel—lung cancer	0.000177	0.00111	CcSEcCtD
Sulfadiazine—Vertigo—Etoposide—lung cancer	0.000177	0.00111	CcSEcCtD
Sulfadiazine—Headache—Vinblastine—lung cancer	0.000176	0.0011	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.000176	0.0011	CcSEcCtD
Sulfadiazine—Leukopenia—Etoposide—lung cancer	0.000176	0.0011	CcSEcCtD
Sulfadiazine—Purpura—Doxorubicin—lung cancer	0.000176	0.0011	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Cisplatin—lung cancer	0.000175	0.0011	CcSEcCtD
Sulfadiazine—Anaphylactoid reaction—Doxorubicin—lung cancer	0.000175	0.0011	CcSEcCtD
Sulfadiazine—Insomnia—Irinotecan—lung cancer	0.000174	0.00109	CcSEcCtD
Sulfadiazine—Vomiting—Topotecan—lung cancer	0.000174	0.00109	CcSEcCtD
Sulfadiazine—Hypoglycaemia—Doxorubicin—lung cancer	0.000173	0.00109	CcSEcCtD
Sulfadiazine—Vertigo—Paclitaxel—lung cancer	0.000173	0.00108	CcSEcCtD
Sulfadiazine—Leukopenia—Paclitaxel—lung cancer	0.000172	0.00108	CcSEcCtD
Sulfadiazine—Rash—Topotecan—lung cancer	0.000172	0.00108	CcSEcCtD
Sulfadiazine—Hypersensitivity—Vinorelbine—lung cancer	0.000172	0.00108	CcSEcCtD
Sulfadiazine—Dermatitis—Topotecan—lung cancer	0.000172	0.00108	CcSEcCtD
Sulfadiazine—Vomiting—Erlotinib—lung cancer	0.000172	0.00108	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Cisplatin—lung cancer	0.000171	0.00107	CcSEcCtD
Sulfadiazine—Headache—Topotecan—lung cancer	0.000171	0.00107	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Gemcitabine—lung cancer	0.000171	0.00107	CcSEcCtD
Sulfadiazine—Rash—Erlotinib—lung cancer	0.000171	0.00107	CcSEcCtD
Sulfadiazine—Dermatitis—Erlotinib—lung cancer	0.00017	0.00107	CcSEcCtD
Sulfadiazine—Convulsion—Etoposide—lung cancer	0.00017	0.00107	CcSEcCtD
Sulfadiazine—Insomnia—Gemcitabine—lung cancer	0.00017	0.00106	CcSEcCtD
Sulfadiazine—Headache—Erlotinib—lung cancer	0.000169	0.00106	CcSEcCtD
Sulfadiazine—Chills—Docetaxel—lung cancer	0.000168	0.00106	CcSEcCtD
Sulfadiazine—Decreased appetite—Irinotecan—lung cancer	0.000168	0.00105	CcSEcCtD
Sulfadiazine—Nausea—Vinblastine—lung cancer	0.000167	0.00105	CcSEcCtD
Sulfadiazine—Convulsion—Paclitaxel—lung cancer	0.000167	0.00105	CcSEcCtD
Sulfadiazine—Anorexia—Cisplatin—lung cancer	0.000167	0.00105	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Irinotecan—lung cancer	0.000166	0.00104	CcSEcCtD
Sulfadiazine—Pancreatitis—Methotrexate—lung cancer	0.000166	0.00104	CcSEcCtD
Sulfadiazine—Pruritus—Vinorelbine—lung cancer	0.000165	0.00104	CcSEcCtD
Sulfadiazine—Arthralgia—Paclitaxel—lung cancer	0.000164	0.00103	CcSEcCtD
Sulfadiazine—Decreased appetite—Gemcitabine—lung cancer	0.000163	0.00102	CcSEcCtD
Sulfadiazine—Nausea—Topotecan—lung cancer	0.000162	0.00102	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000162	0.00102	CcSEcCtD
Sulfadiazine—Nausea—Erlotinib—lung cancer	0.000161	0.00101	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Etoposide—lung cancer	0.00016	0.00101	CcSEcCtD
Sulfadiazine—Diarrhoea—Vinorelbine—lung cancer	0.00016	0.001	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Cisplatin—lung cancer	0.00016	0.001	CcSEcCtD
Sulfadiazine—Ataxia—Doxorubicin—lung cancer	0.000159	0.000997	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Irinotecan—lung cancer	0.000158	0.000988	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Paclitaxel—lung cancer	0.000157	0.000986	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Etoposide—lung cancer	0.000157	0.000984	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Paclitaxel—lung cancer	0.000154	0.000965	CcSEcCtD
Sulfadiazine—Anorexia—Etoposide—lung cancer	0.000153	0.000958	CcSEcCtD
Sulfadiazine—Abdominal pain—Irinotecan—lung cancer	0.000152	0.000955	CcSEcCtD
Sulfadiazine—Body temperature increased—Irinotecan—lung cancer	0.000152	0.000955	CcSEcCtD
Sulfadiazine—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000152	0.000955	CcSEcCtD
Sulfadiazine—Decreased appetite—Cisplatin—lung cancer	0.000152	0.000954	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000151	0.000947	CcSEcCtD
Sulfadiazine—Depression—Methotrexate—lung cancer	0.00015	0.000941	CcSEcCtD
Sulfadiazine—Anorexia—Paclitaxel—lung cancer	0.00015	0.000939	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000149	0.000936	CcSEcCtD
Sulfadiazine—Vomiting—Vinorelbine—lung cancer	0.000149	0.000932	CcSEcCtD
Sulfadiazine—Body temperature increased—Gemcitabine—lung cancer	0.000149	0.000931	CcSEcCtD
Sulfadiazine—Rash—Vinorelbine—lung cancer	0.000147	0.000924	CcSEcCtD
Sulfadiazine—Dermatitis—Vinorelbine—lung cancer	0.000147	0.000923	CcSEcCtD
Sulfadiazine—Stomatitis—Methotrexate—lung cancer	0.000147	0.00092	CcSEcCtD
Sulfadiazine—Headache—Vinorelbine—lung cancer	0.000146	0.000918	CcSEcCtD
Sulfadiazine—Leukopenia—Docetaxel—lung cancer	0.000146	0.000916	CcSEcCtD
Sulfadiazine—Pancreatitis—Doxorubicin—lung cancer	0.000143	0.000899	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000143	0.000898	CcSEcCtD
Sulfadiazine—Insomnia—Paclitaxel—lung cancer	0.000142	0.000891	CcSEcCtD
Sulfadiazine—Hypersensitivity—Irinotecan—lung cancer	0.000142	0.00089	CcSEcCtD
Sulfadiazine—Convulsion—Docetaxel—lung cancer	0.000142	0.000887	CcSEcCtD
Sulfadiazine—Sulfamethoxazole—ALB—lung cancer	0.000141	0.0541	CrCbGaD
Sulfadiazine—Agranulocytosis—Methotrexate—lung cancer	0.000141	0.000881	CcSEcCtD
Sulfadiazine—Decreased appetite—Etoposide—lung cancer	0.000139	0.000874	CcSEcCtD
Sulfadiazine—Arthralgia—Docetaxel—lung cancer	0.000139	0.000871	CcSEcCtD
Sulfadiazine—Nausea—Vinorelbine—lung cancer	0.000139	0.00087	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Etoposide—lung cancer	0.000138	0.000868	CcSEcCtD
Sulfadiazine—Body temperature increased—Cisplatin—lung cancer	0.000138	0.000867	CcSEcCtD
Sulfadiazine—Decreased appetite—Paclitaxel—lung cancer	0.000137	0.000857	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000136	0.000851	CcSEcCtD
Sulfadiazine—Hepatitis—Methotrexate—lung cancer	0.000135	0.000847	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Docetaxel—lung cancer	0.000133	0.000835	CcSEcCtD
Sulfadiazine—Pruritus—Gemcitabine—lung cancer	0.000133	0.000833	CcSEcCtD
Sulfadiazine—Diarrhoea—Irinotecan—lung cancer	0.000132	0.000827	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Etoposide—lung cancer	0.000131	0.000822	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Docetaxel—lung cancer	0.000131	0.000818	CcSEcCtD
Sulfadiazine—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.000129	0.00081	CcSEcCtD
Sulfadiazine—Hypersensitivity—Cisplatin—lung cancer	0.000129	0.000808	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000129	0.000806	CcSEcCtD
Sulfadiazine—Diarrhoea—Gemcitabine—lung cancer	0.000129	0.000805	CcSEcCtD
Sulfadiazine—Erythema multiforme—Methotrexate—lung cancer	0.000128	0.000801	CcSEcCtD
Sulfadiazine—Neuropathy peripheral—Doxorubicin—lung cancer	0.000128	0.000801	CcSEcCtD
Sulfadiazine—Urticaria—Etoposide—lung cancer	0.000127	0.000799	CcSEcCtD
Sulfadiazine—Stomatitis—Doxorubicin—lung cancer	0.000127	0.000797	CcSEcCtD
Sulfadiazine—Anorexia—Docetaxel—lung cancer	0.000127	0.000796	CcSEcCtD
Sulfadiazine—Abdominal pain—Etoposide—lung cancer	0.000127	0.000795	CcSEcCtD
Sulfadiazine—Body temperature increased—Etoposide—lung cancer	0.000127	0.000795	CcSEcCtD
Sulfadiazine—Tinnitus—Methotrexate—lung cancer	0.000126	0.00079	CcSEcCtD
Sulfadiazine—Urticaria—Paclitaxel—lung cancer	0.000125	0.000783	CcSEcCtD
Sulfadiazine—Abdominal pain—Paclitaxel—lung cancer	0.000124	0.000779	CcSEcCtD
Sulfadiazine—Body temperature increased—Paclitaxel—lung cancer	0.000124	0.000779	CcSEcCtD
Sulfadiazine—Dapsone—PTGS2—lung cancer	0.000124	0.0475	CrCbGaD
Sulfadiazine—Vomiting—Irinotecan—lung cancer	0.000123	0.000768	CcSEcCtD
Sulfadiazine—Agranulocytosis—Doxorubicin—lung cancer	0.000122	0.000763	CcSEcCtD
Sulfadiazine—Rash—Irinotecan—lung cancer	0.000122	0.000762	CcSEcCtD
Sulfadiazine—Dermatitis—Irinotecan—lung cancer	0.000121	0.000761	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000121	0.000761	CcSEcCtD
Sulfadiazine—Chills—Methotrexate—lung cancer	0.000121	0.00076	CcSEcCtD
Sulfadiazine—Headache—Irinotecan—lung cancer	0.000121	0.000757	CcSEcCtD
Sulfadiazine—Insomnia—Docetaxel—lung cancer	0.000121	0.000756	CcSEcCtD
Sulfadiazine—Diarrhoea—Cisplatin—lung cancer	0.00012	0.000751	CcSEcCtD
Sulfadiazine—Vomiting—Gemcitabine—lung cancer	0.000119	0.000748	CcSEcCtD
Sulfadiazine—Rash—Gemcitabine—lung cancer	0.000118	0.000742	CcSEcCtD
Sulfadiazine—Dermatitis—Gemcitabine—lung cancer	0.000118	0.000742	CcSEcCtD
Sulfadiazine—Hypersensitivity—Etoposide—lung cancer	0.000118	0.000741	CcSEcCtD
Sulfadiazine—Headache—Gemcitabine—lung cancer	0.000118	0.000737	CcSEcCtD
Sulfadiazine—Hepatitis—Doxorubicin—lung cancer	0.000117	0.000734	CcSEcCtD
Sulfadiazine—Decreased appetite—Docetaxel—lung cancer	0.000116	0.000726	CcSEcCtD
Sulfadiazine—Hypersensitivity—Paclitaxel—lung cancer	0.000116	0.000726	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Docetaxel—lung cancer	0.000115	0.000721	CcSEcCtD
Sulfadiazine—Nausea—Irinotecan—lung cancer	0.000115	0.000718	CcSEcCtD
Sulfadiazine—Pruritus—Etoposide—lung cancer	0.000113	0.000711	CcSEcCtD
Sulfadiazine—Nausea—Gemcitabine—lung cancer	0.000112	0.000699	CcSEcCtD
Sulfadiazine—Vomiting—Cisplatin—lung cancer	0.000111	0.000698	CcSEcCtD
Sulfadiazine—Pruritus—Paclitaxel—lung cancer	0.000111	0.000697	CcSEcCtD
Sulfadiazine—Erythema multiforme—Doxorubicin—lung cancer	0.000111	0.000694	CcSEcCtD
Sulfadiazine—Rash—Cisplatin—lung cancer	0.00011	0.000692	CcSEcCtD
Sulfadiazine—Dermatitis—Cisplatin—lung cancer	0.00011	0.000691	CcSEcCtD
Sulfadiazine—Diarrhoea—Etoposide—lung cancer	0.00011	0.000688	CcSEcCtD
Sulfadiazine—Tinnitus—Doxorubicin—lung cancer	0.000109	0.000684	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Docetaxel—lung cancer	0.000109	0.000683	CcSEcCtD
Sulfadiazine—Diarrhoea—Paclitaxel—lung cancer	0.000108	0.000674	CcSEcCtD
Sulfadiazine—Vertigo—Methotrexate—lung cancer	0.000106	0.000663	CcSEcCtD
Sulfadiazine—Body temperature increased—Docetaxel—lung cancer	0.000105	0.00066	CcSEcCtD
Sulfadiazine—Abdominal pain—Docetaxel—lung cancer	0.000105	0.00066	CcSEcCtD
Sulfadiazine—Leukopenia—Methotrexate—lung cancer	0.000105	0.00066	CcSEcCtD
Sulfadiazine—Chills—Doxorubicin—lung cancer	0.000105	0.000658	CcSEcCtD
Sulfadiazine—Nausea—Cisplatin—lung cancer	0.000104	0.000652	CcSEcCtD
Sulfadiazine—Convulsion—Methotrexate—lung cancer	0.000102	0.000639	CcSEcCtD
Sulfadiazine—Vomiting—Etoposide—lung cancer	0.000102	0.000639	CcSEcCtD
Sulfadiazine—Rash—Etoposide—lung cancer	0.000101	0.000634	CcSEcCtD
Sulfadiazine—Dermatitis—Etoposide—lung cancer	0.000101	0.000633	CcSEcCtD
Sulfadiazine—Headache—Etoposide—lung cancer	0.0001	0.00063	CcSEcCtD
Sulfadiazine—Arthralgia—Methotrexate—lung cancer	0.0001	0.000628	CcSEcCtD
Sulfadiazine—Vomiting—Paclitaxel—lung cancer	0.0001	0.000627	CcSEcCtD
Sulfadiazine—Rash—Paclitaxel—lung cancer	9.92e-05	0.000621	CcSEcCtD
Sulfadiazine—Dermatitis—Paclitaxel—lung cancer	9.91e-05	0.000621	CcSEcCtD
Sulfadiazine—Headache—Paclitaxel—lung cancer	9.85e-05	0.000617	CcSEcCtD
Sulfadiazine—Hypersensitivity—Docetaxel—lung cancer	9.82e-05	0.000615	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Methotrexate—lung cancer	9.61e-05	0.000602	CcSEcCtD
Sulfadiazine—Nausea—Etoposide—lung cancer	9.53e-05	0.000597	CcSEcCtD
Sulfadiazine—Pruritus—Docetaxel—lung cancer	9.43e-05	0.000591	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Methotrexate—lung cancer	9.41e-05	0.00059	CcSEcCtD
Sulfadiazine—Nausea—Paclitaxel—lung cancer	9.34e-05	0.000585	CcSEcCtD
Sulfadiazine—Vertigo—Doxorubicin—lung cancer	9.16e-05	0.000574	CcSEcCtD
Sulfadiazine—Anorexia—Methotrexate—lung cancer	9.16e-05	0.000574	CcSEcCtD
Sulfadiazine—Leukopenia—Doxorubicin—lung cancer	9.12e-05	0.000572	CcSEcCtD
Sulfadiazine—Diarrhoea—Docetaxel—lung cancer	9.12e-05	0.000572	CcSEcCtD
Sulfadiazine—Convulsion—Doxorubicin—lung cancer	8.83e-05	0.000553	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Methotrexate—lung cancer	8.75e-05	0.000549	CcSEcCtD
Sulfadiazine—Insomnia—Methotrexate—lung cancer	8.69e-05	0.000545	CcSEcCtD
Sulfadiazine—Arthralgia—Doxorubicin—lung cancer	8.68e-05	0.000544	CcSEcCtD
Sulfadiazine—Vomiting—Docetaxel—lung cancer	8.48e-05	0.000531	CcSEcCtD
Sulfadiazine—Rash—Docetaxel—lung cancer	8.41e-05	0.000527	CcSEcCtD
Sulfadiazine—Dermatitis—Docetaxel—lung cancer	8.4e-05	0.000526	CcSEcCtD
Sulfadiazine—Decreased appetite—Methotrexate—lung cancer	8.35e-05	0.000523	CcSEcCtD
Sulfadiazine—Headache—Docetaxel—lung cancer	8.35e-05	0.000523	CcSEcCtD
Sulfadiazine—Anaphylactic shock—Doxorubicin—lung cancer	8.32e-05	0.000521	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Methotrexate—lung cancer	8.3e-05	0.00052	CcSEcCtD
Sulfadiazine—Thrombocytopenia—Doxorubicin—lung cancer	8.15e-05	0.00051	CcSEcCtD
Sulfadiazine—Anorexia—Doxorubicin—lung cancer	7.93e-05	0.000497	CcSEcCtD
Sulfadiazine—Nausea—Docetaxel—lung cancer	7.92e-05	0.000496	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Methotrexate—lung cancer	7.86e-05	0.000492	CcSEcCtD
Sulfadiazine—Urticaria—Methotrexate—lung cancer	7.63e-05	0.000478	CcSEcCtD
Sulfadiazine—Abdominal pain—Methotrexate—lung cancer	7.6e-05	0.000476	CcSEcCtD
Sulfadiazine—Body temperature increased—Methotrexate—lung cancer	7.6e-05	0.000476	CcSEcCtD
Sulfadiazine—Musculoskeletal discomfort—Doxorubicin—lung cancer	7.58e-05	0.000475	CcSEcCtD
Sulfadiazine—Insomnia—Doxorubicin—lung cancer	7.52e-05	0.000472	CcSEcCtD
Sulfadiazine—Decreased appetite—Doxorubicin—lung cancer	7.23e-05	0.000453	CcSEcCtD
Sulfadiazine—Gastrointestinal disorder—Doxorubicin—lung cancer	7.18e-05	0.00045	CcSEcCtD
Sulfadiazine—Hypersensitivity—Methotrexate—lung cancer	7.08e-05	0.000444	CcSEcCtD
Sulfadiazine—Gastrointestinal pain—Doxorubicin—lung cancer	6.8e-05	0.000426	CcSEcCtD
Sulfadiazine—Pruritus—Methotrexate—lung cancer	6.8e-05	0.000426	CcSEcCtD
Sulfadiazine—Urticaria—Doxorubicin—lung cancer	6.61e-05	0.000414	CcSEcCtD
Sulfadiazine—Abdominal pain—Doxorubicin—lung cancer	6.58e-05	0.000412	CcSEcCtD
Sulfadiazine—Body temperature increased—Doxorubicin—lung cancer	6.58e-05	0.000412	CcSEcCtD
Sulfadiazine—Diarrhoea—Methotrexate—lung cancer	6.57e-05	0.000412	CcSEcCtD
Sulfadiazine—Hypersensitivity—Doxorubicin—lung cancer	6.13e-05	0.000384	CcSEcCtD
Sulfadiazine—Vomiting—Methotrexate—lung cancer	6.11e-05	0.000383	CcSEcCtD
Sulfadiazine—Rash—Methotrexate—lung cancer	6.06e-05	0.00038	CcSEcCtD
Sulfadiazine—Dermatitis—Methotrexate—lung cancer	6.05e-05	0.000379	CcSEcCtD
Sulfadiazine—Headache—Methotrexate—lung cancer	6.02e-05	0.000377	CcSEcCtD
Sulfadiazine—Pruritus—Doxorubicin—lung cancer	5.89e-05	0.000369	CcSEcCtD
Sulfadiazine—Nausea—Methotrexate—lung cancer	5.71e-05	0.000358	CcSEcCtD
Sulfadiazine—Diarrhoea—Doxorubicin—lung cancer	5.69e-05	0.000357	CcSEcCtD
Sulfadiazine—Vomiting—Doxorubicin—lung cancer	5.29e-05	0.000331	CcSEcCtD
Sulfadiazine—Rash—Doxorubicin—lung cancer	5.25e-05	0.000329	CcSEcCtD
Sulfadiazine—Dermatitis—Doxorubicin—lung cancer	5.24e-05	0.000328	CcSEcCtD
Sulfadiazine—Headache—Doxorubicin—lung cancer	5.21e-05	0.000327	CcSEcCtD
Sulfadiazine—Nausea—Doxorubicin—lung cancer	4.94e-05	0.00031	CcSEcCtD
Sulfadiazine—CYP2C9—Metabolism—COL4A3BP—lung cancer	3.58e-05	0.000624	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—AZIN2—lung cancer	3.58e-05	0.000624	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HSD17B10—lung cancer	3.53e-05	0.000615	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	3.44e-05	0.000599	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	3.34e-05	0.000582	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PLBD1—lung cancer	3.34e-05	0.000581	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CKB—lung cancer	3.28e-05	0.000572	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	3.28e-05	0.000572	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	3.24e-05	0.000564	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTM2—lung cancer	3.09e-05	0.000538	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CNDP2—lung cancer	3.09e-05	0.000538	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTP1—lung cancer	3.08e-05	0.000537	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HSD17B10—lung cancer	3.05e-05	0.000532	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ATP5H—lung cancer	3.05e-05	0.000531	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	3.04e-05	0.00053	CbGpPWpGaD
Sulfadiazine—CYP2C9—Biological oxidations—POMC—lung cancer	3.04e-05	0.000529	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—MTMR3—lung cancer	3e-05	0.000523	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PGAM1—lung cancer	2.92e-05	0.00051	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CKB—lung cancer	2.84e-05	0.000494	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—GSTM1—lung cancer	2.83e-05	0.000494	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	2.8e-05	0.000488	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	2.79e-05	0.000487	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP2A7—lung cancer	2.79e-05	0.000486	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—SDC4—lung cancer	2.73e-05	0.000476	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PLBD1—lung cancer	2.72e-05	0.000473	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—CYP1A1—lung cancer	2.69e-05	0.000468	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	2.67e-05	0.000465	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTM2—lung cancer	2.67e-05	0.000465	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CNDP2—lung cancer	2.67e-05	0.000465	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	2.65e-05	0.000462	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—MTMR3—lung cancer	2.59e-05	0.000452	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PGAM1—lung cancer	2.53e-05	0.000441	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—RRM1—lung cancer	2.49e-05	0.000433	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTA3—lung cancer	2.49e-05	0.000433	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HSD17B10—lung cancer	2.48e-05	0.000433	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP2A7—lung cancer	2.41e-05	0.00042	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—COL4A3BP—lung cancer	2.36e-05	0.000412	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AZIN2—lung cancer	2.36e-05	0.000412	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—SDC4—lung cancer	2.36e-05	0.000411	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—B4GALT5—lung cancer	2.34e-05	0.000408	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CKB—lung cancer	2.31e-05	0.000402	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTA4—lung cancer	2.27e-05	0.000396	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTA2—lung cancer	2.22e-05	0.000386	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CNDP2—lung cancer	2.17e-05	0.000378	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTM2—lung cancer	2.17e-05	0.000378	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—RRM1—lung cancer	2.15e-05	0.000375	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTA3—lung cancer	2.15e-05	0.000375	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTA1—lung cancer	2.14e-05	0.000373	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ABCC3—lung cancer	2.11e-05	0.000369	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—MTMR3—lung cancer	2.11e-05	0.000368	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PGAM1—lung cancer	2.06e-05	0.000359	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—AKR1C1—lung cancer	2.05e-05	0.000357	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—B4GALT5—lung cancer	2.02e-05	0.000352	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ATP5H—lung cancer	2.01e-05	0.00035	CbGpPWpGaD
Sulfadiazine—CYP3A4—Biological oxidations—POMC—lung cancer	2e-05	0.000349	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—UGT1A1—lung cancer	1.99e-05	0.000347	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTA4—lung cancer	1.97e-05	0.000343	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2A7—lung cancer	1.96e-05	0.000342	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.92e-05	0.000335	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—SDC4—lung cancer	1.92e-05	0.000335	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GNG11—lung cancer	1.92e-05	0.000334	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTA2—lung cancer	1.92e-05	0.000334	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTA1—lung cancer	1.85e-05	0.000322	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ABCC3—lung cancer	1.83e-05	0.000319	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALDOA—lung cancer	1.83e-05	0.000318	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PLBD1—lung cancer	1.79e-05	0.000312	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NCOA3—lung cancer	1.77e-05	0.000309	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—AKR1C1—lung cancer	1.77e-05	0.000309	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—RRM1—lung cancer	1.75e-05	0.000305	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTA3—lung cancer	1.75e-05	0.000305	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ADCY1—lung cancer	1.72e-05	0.0003	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ABCG2—lung cancer	1.72e-05	0.0003	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—UGT1A1—lung cancer	1.72e-05	0.0003	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ENO2—lung cancer	1.69e-05	0.000295	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—HPGDS—lung cancer	1.69e-05	0.000295	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PPP2R1B—lung cancer	1.68e-05	0.000293	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GNG11—lung cancer	1.66e-05	0.000289	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.65e-05	0.000287	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—B4GALT5—lung cancer	1.64e-05	0.000287	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTT1—lung cancer	1.64e-05	0.000286	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HSD17B10—lung cancer	1.64e-05	0.000285	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP2A6—lung cancer	1.62e-05	0.000282	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GCLC—lung cancer	1.62e-05	0.000282	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTA4—lung cancer	1.6e-05	0.000279	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALDOA—lung cancer	1.58e-05	0.000275	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.56e-05	0.000273	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTA2—lung cancer	1.56e-05	0.000272	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ENO1—lung cancer	1.54e-05	0.000268	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NCOA3—lung cancer	1.53e-05	0.000267	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CKB—lung cancer	1.52e-05	0.000265	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.51e-05	0.000262	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTA1—lung cancer	1.5e-05	0.000262	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ABCG2—lung cancer	1.49e-05	0.00026	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ADCY1—lung cancer	1.49e-05	0.00026	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ABCC3—lung cancer	1.49e-05	0.000259	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—HPGDS—lung cancer	1.46e-05	0.000255	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ENO2—lung cancer	1.46e-05	0.000255	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PPP2R1B—lung cancer	1.45e-05	0.000253	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—AKR1C1—lung cancer	1.44e-05	0.000251	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.43e-05	0.00025	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CNDP2—lung cancer	1.43e-05	0.000249	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTM2—lung cancer	1.43e-05	0.000249	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTT1—lung cancer	1.42e-05	0.000247	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP2A6—lung cancer	1.4e-05	0.000244	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GCLC—lung cancer	1.4e-05	0.000244	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—UGT1A1—lung cancer	1.4e-05	0.000244	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.4e-05	0.000243	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—MTMR3—lung cancer	1.39e-05	0.000243	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—NQO1—lung cancer	1.36e-05	0.000237	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PGAM1—lung cancer	1.36e-05	0.000236	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GNG11—lung cancer	1.35e-05	0.000235	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.34e-05	0.000234	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ENO1—lung cancer	1.33e-05	0.000231	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.32e-05	0.000231	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.31e-05	0.000228	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2A7—lung cancer	1.29e-05	0.000226	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALDOA—lung cancer	1.28e-05	0.000224	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—SDC4—lung cancer	1.27e-05	0.000221	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NCOA3—lung cancer	1.25e-05	0.000217	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—STK11—lung cancer	1.23e-05	0.000214	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.23e-05	0.000213	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ADCY1—lung cancer	1.21e-05	0.000211	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ABCG2—lung cancer	1.21e-05	0.000211	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP2E1—lung cancer	1.19e-05	0.000208	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ENO2—lung cancer	1.19e-05	0.000207	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—HPGDS—lung cancer	1.19e-05	0.000207	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PPP2R1B—lung cancer	1.18e-05	0.000206	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—NQO1—lung cancer	1.18e-05	0.000205	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.17e-05	0.000203	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA3—lung cancer	1.15e-05	0.000201	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—RRM1—lung cancer	1.15e-05	0.000201	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTT1—lung cancer	1.15e-05	0.000201	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.15e-05	0.000201	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.14e-05	0.000199	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2A6—lung cancer	1.14e-05	0.000199	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GCLC—lung cancer	1.14e-05	0.000199	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTP1—lung cancer	1.14e-05	0.000198	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.14e-05	0.000198	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CAT—lung cancer	1.11e-05	0.000193	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—B4GALT5—lung cancer	1.08e-05	0.000189	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ENO1—lung cancer	1.08e-05	0.000188	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.08e-05	0.000188	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ABCB1—lung cancer	1.08e-05	0.000187	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.06e-05	0.000185	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—STK11—lung cancer	1.06e-05	0.000185	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—TYMS—lung cancer	1.06e-05	0.000184	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA4—lung cancer	1.06e-05	0.000184	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—GSTM1—lung cancer	1.04e-05	0.000182	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA2—lung cancer	1.03e-05	0.000179	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—lung cancer	9.97e-06	0.000174	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTA1—lung cancer	9.92e-06	0.000173	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CYP1A1—lung cancer	9.9e-06	0.000173	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTP1—lung cancer	9.82e-06	0.000171	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ERCC2—lung cancer	9.82e-06	0.000171	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ABCC3—lung cancer	9.81e-06	0.000171	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP2E1—lung cancer	9.69e-06	0.000169	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—NQO1—lung cancer	9.59e-06	0.000167	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CAT—lung cancer	9.56e-06	0.000167	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—EP300—lung cancer	9.5e-06	0.000166	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AKR1C1—lung cancer	9.5e-06	0.000166	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.39e-06	0.000164	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.3e-06	0.000162	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ABCB1—lung cancer	9.3e-06	0.000162	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—UGT1A1—lung cancer	9.22e-06	0.000161	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—TYMS—lung cancer	9.13e-06	0.000159	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—GSTM1—lung cancer	9.03e-06	0.000157	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GNG11—lung cancer	8.89e-06	0.000155	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—STK11—lung cancer	8.64e-06	0.000151	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CYP1A1—lung cancer	8.56e-06	0.000149	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—APOA1—lung cancer	8.49e-06	0.000148	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ERCC2—lung cancer	8.49e-06	0.000148	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALDOA—lung cancer	8.47e-06	0.000148	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NCOA3—lung cancer	8.22e-06	0.000143	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.11e-06	0.000141	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ADCY1—lung cancer	8e-06	0.000139	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ABCG2—lung cancer	8e-06	0.000139	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTP1—lung cancer	8e-06	0.000139	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ENO2—lung cancer	7.84e-06	0.000137	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—HPGDS—lung cancer	7.84e-06	0.000137	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PPP2R1B—lung cancer	7.79e-06	0.000136	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CAT—lung cancer	7.78e-06	0.000136	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CG—lung cancer	7.76e-06	0.000135	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	7.74e-06	0.000135	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTT1—lung cancer	7.61e-06	0.000133	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ABCB1—lung cancer	7.57e-06	0.000132	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GCLC—lung cancer	7.52e-06	0.000131	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2A6—lung cancer	7.52e-06	0.000131	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—TYMS—lung cancer	7.43e-06	0.00013	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—POMC—lung cancer	7.38e-06	0.000129	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—GSTM1—lung cancer	7.35e-06	0.000128	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—APOA1—lung cancer	7.34e-06	0.000128	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—CREBBP—lung cancer	7.19e-06	0.000125	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ENO1—lung cancer	7.13e-06	0.000124	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	7.03e-06	0.000123	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CYP1A1—lung cancer	6.97e-06	0.000121	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ERCC2—lung cancer	6.91e-06	0.00012	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CD—lung cancer	6.82e-06	0.000119	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—ALB—lung cancer	6.73e-06	0.000117	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CG—lung cancer	6.7e-06	0.000117	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP2E1—lung cancer	6.39e-06	0.000111	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—POMC—lung cancer	6.38e-06	0.000111	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—NQO1—lung cancer	6.32e-06	0.00011	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—CREBBP—lung cancer	6.22e-06	0.000108	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—APOA1—lung cancer	5.98e-06	0.000104	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CB—lung cancer	5.94e-06	0.000104	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CD—lung cancer	5.89e-06	0.000103	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTGS2—lung cancer	5.89e-06	0.000103	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—ALB—lung cancer	5.82e-06	0.000101	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.72e-06	9.97e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—STK11—lung cancer	5.7e-06	9.93e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CG—lung cancer	5.46e-06	9.51e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTP1—lung cancer	5.27e-06	9.19e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—POMC—lung cancer	5.19e-06	9.05e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CB—lung cancer	5.14e-06	8.95e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PTEN—lung cancer	5.13e-06	8.95e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CAT—lung cancer	5.13e-06	8.94e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTGS2—lung cancer	5.09e-06	8.87e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—CREBBP—lung cancer	5.06e-06	8.82e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ABCB1—lung cancer	4.99e-06	8.7e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—TYMS—lung cancer	4.9e-06	8.54e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—EP300—lung cancer	4.9e-06	8.53e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—GSTM1—lung cancer	4.85e-06	8.44e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CD—lung cancer	4.8e-06	8.36e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—ALB—lung cancer	4.73e-06	8.25e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CYP1A1—lung cancer	4.59e-06	8.01e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ERCC2—lung cancer	4.56e-06	7.94e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PTEN—lung cancer	4.44e-06	7.74e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—EP300—lung cancer	4.23e-06	7.38e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CB—lung cancer	4.18e-06	7.29e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTGS2—lung cancer	4.14e-06	7.22e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—APOA1—lung cancer	3.94e-06	6.87e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—PIK3CA—lung cancer	3.62e-06	6.31e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PTEN—lung cancer	3.61e-06	6.3e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CG—lung cancer	3.6e-06	6.27e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—EP300—lung cancer	3.45e-06	6e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—POMC—lung cancer	3.42e-06	5.97e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—CREBBP—lung cancer	3.34e-06	5.81e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CD—lung cancer	3.16e-06	5.51e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—PIK3CA—lung cancer	3.13e-06	5.46e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—ALB—lung cancer	3.12e-06	5.44e-05	CbGpPWpGaD
Sulfadiazine—CYP2E1—Metabolism—AKT1—lung cancer	2.96e-06	5.16e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CB—lung cancer	2.76e-06	4.8e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTGS2—lung cancer	2.73e-06	4.76e-05	CbGpPWpGaD
Sulfadiazine—CYP2C8—Metabolism—AKT1—lung cancer	2.56e-06	4.46e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—PIK3CA—lung cancer	2.55e-06	4.44e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PTEN—lung cancer	2.38e-06	4.15e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—EP300—lung cancer	2.27e-06	3.96e-05	CbGpPWpGaD
Sulfadiazine—CYP2C9—Metabolism—AKT1—lung cancer	2.08e-06	3.63e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—PIK3CA—lung cancer	1.68e-06	2.93e-05	CbGpPWpGaD
Sulfadiazine—CYP3A4—Metabolism—AKT1—lung cancer	1.37e-06	2.39e-05	CbGpPWpGaD
